Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
CNY 14.12
(-0.14%)
CNY 14.12
(-0.14%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 599.1 Million CNY | 178.49% |
| 2022 | 215.12 Million CNY | -58.07% |
| 2021 | 513 Million CNY | 4768.02% |
| 2020 | 10.53 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | -100.0% |
| 2012 | 47 Million CNY | 0.0% |
| 2011 | 47 Million CNY | 2.17% |
| 2010 | 46 Million CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 667.1 Million CNY | 11.48% |
| 2024 Q2 | 598.39 Million CNY | -0.06% |
| 2024 Q1 | 598.73 Million CNY | -0.06% |
| 2023 FY | 599.1 Million CNY | 178.49% |
| 2023 Q2 | 313.43 Million CNY | 46.35% |
| 2023 Q4 | 599.1 Million CNY | -15.98% |
| 2023 Q3 | 713.06 Million CNY | 127.5% |
| 2023 Q1 | 214.17 Million CNY | -0.44% |
| 2022 Q3 | 352.61 Million CNY | 131.0% |
| 2022 Q1 | 505.67 Million CNY | -1.43% |
| 2022 Q4 | 215.12 Million CNY | -38.99% |
| 2022 Q2 | 152.64 Million CNY | -69.81% |
| 2022 FY | 215.12 Million CNY | -58.07% |
| 2021 Q3 | 500.42 Million CNY | 0.0% |
| 2021 FY | 513 Million CNY | 4768.02% |
| 2021 Q1 | 1.00 CNY | -100.0% |
| 2021 Q2 | 500.42 Million CNY | 50042252882.75% |
| 2021 Q4 | 513 Million CNY | 2.51% |
| 2020 FY | 10.53 Million CNY | 0.0% |
| 2020 Q4 | 10.53 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | -100.0% |
| 2013 Q1 | 37 Million CNY | -21.28% |
| 2013 Q2 | - CNY | -100.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2012 Q4 | 47 Million CNY | 0.0% |
| 2012 Q1 | 47 Million CNY | 0.0% |
| 2012 Q2 | 47 Million CNY | 0.0% |
| 2012 Q3 | 47 Million CNY | 0.0% |
| 2012 FY | 47 Million CNY | 0.0% |
| 2011 FY | 47 Million CNY | 2.17% |
| 2011 Q2 | 93 Million CNY | 0.0% |
| 2011 Q3 | 93 Million CNY | 0.0% |
| 2011 Q4 | 47 Million CNY | -49.46% |
| 2010 Q4 | 46 Million CNY | 0.0% |
| 2010 FY | 46 Million CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |